Avanos Medical, Inc. affirms revenue guidance for the full year of 2022. For the year, company affirms its guidance for 2022 net sales to between $815 million and $835 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.18 USD | +0.37% |
|
+0.47% | -14.49% |
05-13 | Avanos Medical, Inc. Appoints Sigfrido Delgado as Senior Vice President, Integrated Supply Chain | CI |
05-02 | Avanos Medical to Seek M&A Opportunities | CI |
![Consensus](/images/consensus_flch.gif)
1st Jan change | Capi. | |
---|---|---|
-14.49% | 828M | |
-4.72% | 182B | |
-2.83% | 103B | |
-5.01% | 66.94B | |
+15.53% | 46.73B | |
-8.53% | 45.14B | |
+5.82% | 41.57B | |
+17.67% | 30.48B | |
+14.00% | 24.26B | |
-8.08% | 23.58B |
- Stock Market
- Equities
- AVNS Stock
- News Avanos Medical, Inc.
- Avanos Medical, Inc. Affirms Revenue Guidance for the Full-Year 2022